← Open Payments lookup

JAY JONES: Open Payments

NPI 1740235308 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$317 in 16 payments from 11 companies in 2025. Trend: 2023 $201 · 2024 $101 · 2025 $317

Food & beverage: $317
CompanyPaymentsAmount
Abbott Laboratories3$71
PFIZER INC.3$69
GlaxoSmithKline, LLC.2$29
Madrigal Pharmaceuticals1$24
Sumitomo Pharma America, Inc.1$23
Gilead Sciences, Inc.1$20
Otsuka America Pharmaceutical, Inc.1$20
Medtronic, Inc.1$16
ABBVIE INC.1$16
Amgen Inc.1$15

Products named: PREVNAR 20, FREESTYLE LIBRE 3, SHINGRIX, REZDIFFRA, GEMTESA, ESPRIT, REXULTI, O-ARM.

Industry payments across TX — which companies pay providers there.